PANEL: Achieving diversity and inclusion in patient recruitment

• DEI in rare diseases: how to ensure your trial participants represent the overall population in trials with limited patient numbers
• Navigating FDA regulations and devising a strategy for diversity and inclusion
• Building trust and relationships with communities who may not traditionally participate in clinical trials
• Working with advocacy groups to increase trial diversity and patient numbers

MODERATOR:

Robert Loll, Senior Vice President, Business Development and Strategic Planning, Praxis